The AAP diverges from CDC guidelines, advocating for Covid-19 vaccines in young children, igniting debate over vaccine policy ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Monument Therapeutics partners with FNIH to advance MT1988, a promising treatment for cognitive impairment in schizophrenia, ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

Why pharma and all stakeholders in the healthcare ecosystem should undertake a fundamental shift in how evidence to support ...

The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Ron Lanton, partner, Lanton Law, warns that recent changes to federal vaccine recommendations could trigger extensive litigation as insurers, providers, and patients face new access and coverage ...

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.

A look back and ahead at the growing trend—sparked recently by the GLP-1 trail—and new ways to harness this Rx access channel ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...